Metavasi Capital LP Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001864835
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2026 · 21 positions · Total reported value $276.29M · Top-10 concentration 81.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 86.5% · 13 new · 7 cut · 12 exited
Active Share (vs S&P 500): 94.4% · vs QQQ: 93.6% — share of the book that differs from index weights (higher = more active) · ranking
In its Q1 2026 13F filing, Metavasi Capital LP disclosed 21 equity positions with a combined reported value of $276.29M. The filing implies a focused portfolio: its ten largest positions account for 81.0% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q1 2026 were TLT ($108.32M), APP ($24.34M), DAVE ($20.47M). By sector, the heaviest allocations are Consumer Discretionary 24.5%, Technology 15.1%. Versus the prior quarter, allocation shifted toward Other (+28.1pp), Health Care (+3.4pp) and away from Energy (-0.8pp), Consumer Discretionary (-5.4pp).
Versus the prior quarter, Metavasi Capital LP opened 13 new positions, trimmed 7 and fully exited 12, a turnover rate of 86.5% of positions. The portfolio's overlap with the prior quarter was 55% of names.
The largest new positions opened in Q1 2026 were SPOT ($11.01M), AKAM ($5.95M), TWST ($4.75M).
Of the 12 positions fully exited versus the prior quarter, the largest were BLND ($19.41M), TWLO ($12.46M), CPNG ($6.34M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2026)
- SPOT SPOTIFY TECHNOLOGY S A · $11.01M
- AKAM AKAMAI TECHNOLOGIES INC · $5.95M
- TWST TWIST BIOSCIENCE CORP · $4.75M
- HIMS HIMS & HERS HEALTH INC · $4.61M
Fully Exited (vs previous quarter)
- BLND BLEND LABS INC · prev qtr: $19.41M
- TWLO TWILIO INC · prev qtr: $12.46M
- CPNG COUPANG INC · prev qtr: $6.34M
- RKT ROCKET COS INC · prev qtr: $5.42M
- WING WINGSTOP INC · prev qtr: $5.15M
- RDDT REDDIT INC · prev qtr: $4.60M
- EVLV EVOLV TECHNOLOGIES HLDNGS IN · prev qtr: $4.52M
- SE SEA LTD · prev qtr: $4.46M
Insider Transactions (Form 4)
Latest Metavasi Capital LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Metavasi Capital LP, based in Larchmont, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 25 positions worth $282.53M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: LARCHMONT, NY, United States
- SEC registration: 801-120146 (status: Approved), registered 2021-01-13
- Regulatory AUM (Form ADV): $420.59M as of 2026-03-17
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 1 hedge funds
Portfolio Structure
- 25 positions · $282.53M reported value (Q3 2026)
- Top 10 holdings = 63.0% of reported value
- Largest position: DAVE (DAVE INC) at 10.6%
- Average position size: $11.30M
Sector Tilt
- Financials 28.0%
- Information Technology 25.9%
- Consumer Discretionary 20.3%
- (classified holdings cover 83% of value)
Quarterly Activity
- Q3 2026: 13 new, 5 added, 7 reduced, 12 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.25M | $108.32M | 39.20% | Add | |
| 2 |
|
61.17K | $24.34M | 8.81% | Add | |
| 3 |
|
117.59K | $20.47M | 7.41% | Add | |
| 4 |
|
82.12K | $12.33M | 4.46% | Add | |
| 5 |
|
122.27K | $11.91M | 4.31% | Reduce | |
| 6 |
|
98.11K | $11.52M | 4.17% | Reduce | |
| 7 |
|
22.71K | $11.01M | 3.99% | New | |
| 8 |
|
26.00K | $8.17M | 2.96% | Add | |
| 9 |
|
58.03K | $7.86M | 2.85% | Reduce | |
| 10 |
|
66.00K | $7.73M | 2.80% | Add | |
| 11 |
|
1.04M | $7.57M | 2.74% | Reduce | |
| 12 |
|
106.79K | $7.40M | 2.68% | Hold | |
| 13 |
|
51.80K | $5.95M | 2.15% | New | |
| 14 |
|
54.23K | $5.74M | 2.08% | Reduce | |
| 15 |
|
250.00K | $5.49M | 1.99% | Add | |
| 16 |
|
125.00K | $5.11M | 1.85% | Add | |
| 17 |
|
100.00K | $4.75M | 1.72% | New | |
| 18 |
|
222.00K | $4.61M | 1.67% | New | |
| 19 |
|
279.48K | $4.02M | 1.45% | Reduce | |
| 20 |
|
382.30K | $1.98M | 0.72% | Reduce | |
| 21 |
|
481.77K | $4.82K | 0.00% | Hold | |
FAQ
What did Metavasi Capital LP buy in 2026-Q1?
In its 2026-Q1 13F filing, Metavasi Capital LP reported 21 equity positions worth $276.29M in aggregate; its largest disclosed positions were TLT ($108.32M), APP ($24.34M), DAVE ($20.47M).
How large is Metavasi Capital LP's portfolio?
Metavasi Capital LP reported $276.29M of long equity holdings across 21 positions as of 2026-Q1. Top-10 holdings account for 81.0% of reported value.
What is Metavasi Capital LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.